Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

The Rev II Trial: Lenalidomide and Dexamethasone As Second Line Treatment in Myeloma Followed By Extended Lenalidomid Vs Len/Dex

Johan Lund, MD, Sigrid Karstorp, MD, Evren Alici, MD PhD, Astrid Gruber, MD PhD, Birgitta Lauri, MD, Cecilie Blimark, MD PhD, Agneta Swedin, MD PhD, Markus Hansson, MD PhD, Karin Forsberg, MD, Lucia Ahlberg, MD, Carlsson Conny, MD, Anders Waage, MD PhD, Peter Gimsing, Annette Juul Vangsted, MD PhD, Ulf Christian Frølund, MD, Mats Hardling, Ulf-Henrik Mellqvist, MD PhD, Hareth Nahi

Blood (2015) 126 (23): 3047.

https://doi.org/10.1182/blood.V126.23.3047.3047

Published: 2015

Journal Articles

Real World Data In Myeloma: Experiences From The Swedish Population-Based Registry On 2494 Myeloma Patients Diagnosed 2008-2011

Cecilie Blimark, MD, Erik Holmberg, PhD, Gunnar Juliusson, MD, PhD, Hareth Nahi, MD, PhD, Forsberg Karin, MD, PhD, Ingemar Turesson, MD, PhD, Lucia Ahlberg, MD., PhD., Ronald Svensson, MD, Olle Linder, MD, Kristina Carlsson, MD, PhD, Sigurdur Y Kristinsson, M.D., Ph.D.

Blood (2013) 122 (21): 1972.

https://doi.org/10.1182/blood.V122.21.1972.1972

Published: 2013

Journal Articles

Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial

Blood (2013) 121 (23): 4647–4654.

https://doi.org/10.1182/blood-2012-11-464503

Published: 2013

Journal Articles

Is Multiple Myeloma a Chronic Disease? A Population Based Study Comparing 1843 Patients to a Matched Swedish Population.

Hareth Nahi, Johan Liwing, Anders Aldrin, Johan Andreasson, Cecilie Blimark, MD, Kristina Carlson, Jon Enestig, Max Flogegård, Karin Forsberg, Astrid Gruber, MD, PhD, Peter Johansson, MD, PhD, Helene Kviele, Birgitta Lauri, Ulf-Henrik Mellqvist, MD, PhD, Per Näsman, Agneta Swedin, Magnus Svensson, Katarina Uttervall, MD, PhD-student, Johan Aschan, MD, PhD

Blood (2012) 120 (21): 2970.

https://doi.org/10.1182/blood.V120.21.2970.2970

Published: 2012

Journal Articles

Multiple Myeloma and Infections: A Population-Based Study Based On 9,610 Multiple Myeloma Patients

Cecilie Blimark, M.D., Ulf-Henrik Mellqvist, MD, PhD, Ola Landgren, M.D., Ph.D., Magnus Björkholm, MD, PhD, Malin L Hultcrantz, MD, Christian Kjellander, MD, Ingemar Turesson, MD, PhD, Erik Holmberg, PhD, Sigurdur Y Kristinsson, M.D., Ph.D.

Blood (2012) 120 (21): 945.

https://doi.org/10.1182/blood.V120.21.945.945

Published: 2012

Journal Articles

Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study

Ebba K. Lindqvist, Lynn R. Goldin, Ola Landgren, Cecilie Blimark, Ulf-Henrik Mellqvist, Ingemar Turesson, Anders Wahlin, Magnus Björkholm, Sigurdur Y. Kristinsson

Blood (2011) 118 (24): 6284–6291.

https://doi.org/10.1182/blood-2011-04-347559

Published: 2011

Includes: Supplemental data

Journal Articles

Monoclonal Gammopathy of Undetermined Significance and Risk of Infections: A Population-Based Study

Sigurdur Y. Kristinsson, MD, PhD, Tang Min, PhD, Ruth Pfeiffer, PhD, Magnus Björkholm, MD, PhD, Lynn Goldin, PhD, Cecilie Blimark, MD, Ulf-Henrik Mellqvist, MD, PhD, Anders Wahlin, MD, PhD, Ingemar Turesson, MD, PhD, Ola Landgren, MD, PhD

Blood (2010) 116 (21): 4053.

https://doi.org/10.1182/blood.V116.21.4053.4053

Published: 2010

Journal Articles

Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study

Sigurdur Y. Kristinsson, Min Tang, Ruth M. Pfeiffer, Magnus Björkholm, Cecilie Blimark, Ulf-Henrik Mellqvist, Anders Wahlin, Ingemar Turesson, Ola Landgren

Blood (2010) 116 (15): 2651–2655.

https://doi.org/10.1182/blood-2010-04-282848

Published: 2010

Journal Articles

Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study

Sigurdur Y. Kristinsson, Ruth M. Pfeiffer, Magnus Björkholm, Lynn R. Goldin, Sam Schulman, Cecilie Blimark, Ulf-Henrik Mellqvist, Anders Wahlin, Ingemar Turesson, Ola Landgren

Blood (2010) 115 (24): 4991–4998.

https://doi.org/10.1182/blood-2009-11-252072

Published: 2010

Journal Articles

Arterial and Venous Thrombosis in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma: A Population-Based Study.

Sigurdur Y Kristinsson, M.D., Ph.D., Ruth Pfeiffer, PhD, Magnus Bjorkholm, MD, PhD, Lynn R Goldin, PhD, Sam Schulman, MD, PhD, Cecilie Blimark, MD, Ulf-Henrik Mellqvist, MD, PhD, Anders Wahlin, MD, PhD, Ingemar Turesson, MD, PhD, Ola Landgren, M.D., Ph.D.

Blood (2009) 114 (22): 1872.

https://doi.org/10.1182/blood.V114.22.1872.1872

Published: 2009

Journal Articles

Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden

Ola Landgren, Sigurdur Y. Kristinsson, Lynn R. Goldin, Neil E. Caporaso, Cecilie Blimark, Ulf-Henrik Mellqvist, Anders Wahlin, Magnus Bjorkholm, Ingemar Turesson

Blood (2009) 114 (4): 791–795.

https://doi.org/10.1182/blood-2008-12-191676

Published: 2009

Journal Articles

Familial Aggregation of Multiple Myeloma and Its Precursor Monoclonal Gammopathy of Undetermined Significance (MGUS): A Population-Based Study in Sweden.

Sigurdur Y Kristinsson, M.D., Magnus Bjorkholm, MD, PhD, Lynn R. Goldin, Ph.D., Cecilie Blimark, M.D., Ulf-Henrik Mellqvist, MD, PhD, Anders Wahlin, MD, PhD, Ingemar Turesson, MD, PhD, Ola Landgren, M.D., Ph.D.

Blood (2008) 112 (11): 1678.

https://doi.org/10.1182/blood.V112.11.1678.1678

Published: 2008

Journal Articles

Increased Risk of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Lymphoproliferative Tumors among 14689 First-Degree Relatives of 4488 MGUS Patients in Sweden.

Ola Landgren, MD, PhD, Sigurdur Y. Kristinsson, MD, Lynn R. Goldin, PhD, Neil E. Caporaso, MD, Cecilie Blimark, MD, Ulf-Henrik Mellqvist, MD, PhD, Anders Wahlin, MD, PhD, Magnus Bjorkholm, MD, PhD, Ingemar Turesson, MD, PhD

Blood (2007) 110 (11): 660.

https://doi.org/10.1182/blood.V110.11.660.660

Published: 2007

NARROW

The Rev II Trial: Lenalidomide and Dexamethasone As Second Line Treatment in Myeloma Followed By Extended Lenalidomid Vs Len/Dex

Real World Data In Myeloma: Experiences From The Swedish Population-Based Registry On 2494 Myeloma Patients Diagnosed 2008-2011

Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial

Is Multiple Myeloma a Chronic Disease? A Population Based Study Comparing 1843 Patients to a Matched Swedish Population.

Multiple Myeloma and Infections: A Population-Based Study Based On 9,610 Multiple Myeloma Patients

Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study

Monoclonal Gammopathy of Undetermined Significance and Risk of Infections: A Population-Based Study

Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study

Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study

Arterial and Venous Thrombosis in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma: A Population-Based Study.

Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden

Familial Aggregation of Multiple Myeloma and Its Precursor Monoclonal Gammopathy of Undetermined Significance (MGUS): A Population-Based Study in Sweden.

Increased Risk of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Lymphoproliferative Tumors among 14689 First-Degree Relatives of 4488 MGUS Patients in Sweden.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only